These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8083235)

  • 1. High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130.
    Ward LD; Howlett GJ; Discolo G; Yasukawa K; Hammacher A; Moritz RL; Simpson RJ
    J Biol Chem; 1994 Sep; 269(37):23286-9. PubMed ID: 8083235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6.receptor complex.
    Ward LD; Hammacher A; Howlett GJ; Matthews JM; Fabri L; Moritz RL; Nice EC; Weinstock J; Simpson RJ
    J Biol Chem; 1996 Aug; 271(33):20138-44. PubMed ID: 8702737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
    Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
    Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interleukin-6 (IL-6) partial antagonist (Q159E,T162P)IL-6 interacts with the IL-6 receptor and gp130 but fails to induce a stable hexameric receptor complex.
    Hammacher A; Simpson RJ; Nice EC
    J Biol Chem; 1996 Mar; 271(10):5464-73. PubMed ID: 8621403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling.
    Paonessa G; Graziani R; De Serio A; Savino R; Ciapponi L; Lahm A; Salvati AL; Toniatti C; Ciliberto G
    EMBO J; 1995 May; 14(9):1942-51. PubMed ID: 7744001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
    J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production.
    Igaz P; Horváth A; Horváth B; Szalai C; Pállinger E; Rajnavölgyi E; Tóth S; Rose-John S; Falus A
    Immunol Lett; 2000 Mar; 71(3):143-8. PubMed ID: 10722865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.
    Gaillard JP; Mani JC; Liautard J; Klein B; Brochier J
    Eur Cytokine Netw; 1999 Mar; 10(1):43-8. PubMed ID: 10210772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A complex of the soluble interleukin-6 receptor and interleukin-6 is internalized via the signal transducer gp130.
    Graeve L; Korolenko TA; Hemmann U; Weiergräber O; Dittrich E; Heinrich PC
    FEBS Lett; 1996 Dec; 399(1-2):131-4. PubMed ID: 8980136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-11 signals through the formation of a hexameric receptor complex.
    Barton VA; Hall MA; Hudson KR; Heath JK
    J Biol Chem; 2000 Nov; 275(46):36197-203. PubMed ID: 10948192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro reconstitution of recognition and activation complexes between interleukin-6 and gp130.
    Chow D; Ho J; Nguyen Pham TL; Rose-John S; Garcia KC
    Biochemistry; 2001 Jun; 40(25):7593-603. PubMed ID: 11412113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex.
    Horsten U; Müller-Newen G; Gerhartz C; Wollmer A; Wijdenes J; Heinrich PC; Grötzinger J
    J Biol Chem; 1997 Sep; 272(38):23748-57. PubMed ID: 9295319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
    Jostock T; Müllberg J; Ozbek S; Atreya R; Blinn G; Voltz N; Fischer M; Neurath MF; Rose-John S
    Eur J Biochem; 2001 Jan; 268(1):160-7. PubMed ID: 11121117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfide bond structure and N-glycosylation sites of the extracellular domain of the human interleukin-6 receptor.
    Cole AR; Hall NE; Treutlein HR; Eddes JS; Reid GE; Moritz RL; Simpson RJ
    J Biol Chem; 1999 Mar; 274(11):7207-15. PubMed ID: 10066782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor alpha mutated in the predicted gp130-binding interface.
    Salvati AL; Lahm A; Paonessa G; Ciliberto G; Toniatti C
    J Biol Chem; 1995 May; 270(20):12242-9. PubMed ID: 7744875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function analysis of human IL-6 receptor: dissociation of amino acid residues required for IL-6-binding and for IL-6 signal transduction through gp130.
    Yawata H; Yasukawa K; Natsuka S; Murakami M; Yamasaki K; Hibi M; Taga T; Kishimoto T
    EMBO J; 1993 Apr; 12(4):1705-12. PubMed ID: 8467812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yeast expression of the cytokine receptor domain of the soluble interleukin-6 receptor.
    Vollmer P; Peters M; Ehlers M; Yagame H; Matsuba T; Kondo M; Yasukawa K; Büschenfelde KH; Rose-John S
    J Immunol Methods; 1996 Nov; 199(1):47-54. PubMed ID: 8960097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6.
    Peters M; Blinn G; Solem F; Fischer M; Meyer zum Büschenfelde KH; Rose-John S
    J Immunol; 1998 Oct; 161(7):3575-81. PubMed ID: 9759879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
    J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.